Decroo T, Rasschaert F, Telfer B, Remartinez D, Laga M, et al.
2013-07-30 • International Health
2013-07-30 • International Health
In sub-Saharan Africa models of care need to adapt to support continued scale up of antiretroviral therapy (ART) and retain millions in care. Task shifting, coupled with community partic...
Bemelmans M, van den Akker T, Ford NP, Philips M, Zachariah R, et al.
2010-12-01 • Tropical Medicine and International Health
2010-12-01 • Tropical Medicine and International Health
Objective To describe how district-wide access to HIV/AIDS care was achieved and maintained in Thyolo District, Malawi. Method In mid-2003, the Ministry of Health and Médecins Sans Fro...
The people of the Democratic Republic of Congo for decades have been living in a situation of chronic crisis. Violence, population displacement and the destruction of infrastructure and ...
Park JS, Grais RF, Taljaard M, Nakimuli-Mpungu E, Jehan F, et al.
2021-05-01 • Lancet Global Health
2021-05-01 • Lancet Global Health
This paper shows the scale of global health research and the context in which we frame the subsequent papers in the Series. In this Series paper, we provide a historical perspective on c...
Rao VB, Johari N, du Cros PAK, Messina J, Ford NP, et al.
2015-05-05 • Lancet Infectious Diseases
2015-05-05 • Lancet Infectious Diseases
An estimated 150 million people worldwide are infected with hepatitis C virus (HCV). HIV co-infection accelerates the progression of HCV and represents a major public health challenge. W...
O'Brien DP, Ford NP, Djirmay AG, Calmy A, Victoria M, et al.
2019-01-25 • Journal of Acquired Immune Deficiency Syndromes (1999)
2019-01-25 • Journal of Acquired Immune Deficiency Syndromes (1999)
Evidence suggests that there are important interactions between HIV and Female Genital Schistosomiasis (FGS) that may have significant effects on individual and population health. Howeve...
INTRODUCTION There is conflicting evidence and practice regarding the use of the non-nucleoside reverse transcriptase inhibitors (NNRTI) efavirenz (EFV) and nevirapine (NVP) in first...
Chu KM, Boulle AM, Ford NP, Goemaere E, Asselman V, et al.
2010-02-17 • PLOS One
2010-02-17 • PLOS One
BACKGROUND: The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen contain...
2010-03-31 • BMC International Health and Human Rights
2010-03-31 • BMC International Health and Human Rights
ABSTRACT: BACKGROUND: Recent evidence from developed and developing countries shows clear clinical and public health benefit to starting antiretroviral therapy (ART) earlier. While discu...
